Business · 09/02/2024Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting on Influenza Vaccine Strains
Summary
The Food and Drug Administration (FDA) is hosting a public meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss and recommend the selection of influenza virus strains for the 2024 to 2025 influenza season.